Publications
Below you can view some of the research we have published.
Nirmatrelvir, Molnupiravir, and Remdesivir maintain potent in vitro activity against the SARS-CoV-2 Omicron variant
Romel Rosales, Briana L. McGovern, M. Luis Rodriguez, Devendra K. Rai, Rhonda D. Cardin, Annaliesa S. Anderson, PSP study group, Emilia Mia Sordillo, Harm van Bakel, Viviana Simon, Adolfo García-Sastre, Kris M. White
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
Kris M White , Romel Rosales , Soner Yildiz , Thomas Kehrer , Lisa Miorin , Elena Moreno , Sonia Jangra , Melissa B Uccellini , Raveen Rathnasinghe , Lynda Coughlan , Carles Martinez-Romero , Jyoti Batra , Ajda Rojc , Mehdi Bouhaddou , Jacqueline M Fabius , Kirsten Obernier , Marion Dejosez , María José Guillén , Alejandro Losada , Pablo Avilés , Michael Schotsaert , Thomas Zwaka , Marco Vignuzzi , Kevan M Shokat , Nevan J Krogan , Adolfo García-Sastre